Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
21.02 USD | -4.54% | +4.68% | -9.98% |
04-30 | Akero Therapeutics Appoints Scott Gangloff as Chief Technology Officer | CI |
03-08 | Akero Therapeutics Raises $367 Million From Share Offering | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.98% | 1.45B | |
+2.93% | 108B | |
+7.02% | 23.46B | |
-14.60% | 21.72B | |
-7.05% | 18.64B | |
-38.55% | 17.45B | |
-8.83% | 17.19B | |
+5.51% | 13.99B | |
+37.49% | 12.53B | |
+329.39% | 8.81B |
- Stock Market
- Equities
- AKRO Stock
- News Akero Therapeutics, Inc.
- Akero Therapeutics' Q4 Loss Widens; Cash Expected to Fund Operations Into 2026